Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Clinical trial NCT02025712 · UNKNOWN
Trial details
- NCT number
- NCT02025712
- Sponsor
- Organisation for Oncology and Translational Research
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2016-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.